Literature DB >> 34592051

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis.

Sonalie Patel1, Michelle T Martin2,3, Steven L Flamm4.   

Abstract

Entities:  

Keywords:  cirrhosis; decompensated; direct-acting antivirals; hepatitis C virus; retreatment; salvage therapy; sofosbuvir; velpatasvir; voxilaprevir

Mesh：

Substances：

Year:  2021        PMID： 34592051     DOI： 10.1111/liv.15075

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  1 in total

1.  Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis.

Authors:  Jing Xie; Bin Xu; Linlin Wei; Chunyang Huang; Wei Liu
Journal:  Infect Dis Ther       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.